These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 17496286)

  • 1. Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2.
    Edmond JJ; French JK; Aylward PE; Wong CK; Stewart RA; Williams BF; De Pasquale CG; O'connell RL; Van den Berg K; Van de Werf FJ; Simes RJ; White HD;
    Eur Heart J; 2007 Jun; 28(12):1418-24. PubMed ID: 17496286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center.
    Gurm HS; Rajagopal V; Fathi R; Vivekanathan D; Yadav JS; Bhatt DL; Ellis SG; Lincoff AM; Topol EJ
    Am J Cardiol; 2005 Mar; 95(6):716-21. PubMed ID: 15757596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
    Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
    Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: comparison of prehospital tirofiban versus fibrinolysis before direct PCI.
    Möckel M; Bocksch W; Strohm S; Kühnle Y; Vollert J; Nibbe L; Dietz R
    Int J Cardiol; 2005 Aug; 103(2):193-200. PubMed ID: 16080980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.
    Simes RJ; O'Connell RL; Aylward PE; Varshavsky S; Diaz R; Wilcox RG; Armstrong PW; Granger CB; French JK; Van de Werf F; Marschner IC; Califf R; White HD;
    Am Heart J; 2010 Jun; 159(6):988-97. PubMed ID: 20569711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitated PCI in patients with ST-elevation myocardial infarction.
    Ellis SG; Tendera M; de Belder MA; van Boven AJ; Widimsky P; Janssens L; Andersen HR; Betriu A; Savonitto S; Adamus J; Peruga JZ; Kosmider M; Katz O; Neunteufl T; Jorgova J; Dorobantu M; Grinfeld L; Armstrong P; Brodie BR; Herrmann HC; Montalescot G; Neumann FJ; Effron MB; Barnathan ES; Topol EJ;
    N Engl J Med; 2008 May; 358(21):2205-17. PubMed ID: 18499565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial.
    Di Mario C; Dudek D; Piscione F; Mielecki W; Savonitto S; Murena E; Dimopoulos K; Manari A; Gaspardone A; Ochala A; Zmudka K; Bolognese L; Steg PG; Flather M;
    Lancet; 2008 Feb; 371(9612):559-68. PubMed ID: 18280326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin during primary PCI in acute myocardial infarction.
    Stone GW; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Dangas G; Wong SC; Kirtane AJ; Parise H; Mehran R;
    N Engl J Med; 2008 May; 358(21):2218-30. PubMed ID: 18499566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial.
    Montalescot G; Gallo R; White HD; Cohen M; Steg PG; Aylward PE; Bode C; Chiariello M; King SB; Harrington RA; Desmet WJ; Macaya C; Steinhubl SR;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1083-91. PubMed ID: 19926048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block: importance of QRS duration and early ST-segment resolution after fibrinolytic therapy.
    Wong CK; Gao W; Stewart RA; van Pelt N; French JK; Aylward PE; White HD;
    Circulation; 2006 Aug; 114(8):783-9. PubMed ID: 16908761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.
    Steg PG; Bonnefoy E; Chabaud S; Lapostolle F; Dubien PY; Cristofini P; Leizorovicz A; Touboul P;
    Circulation; 2003 Dec; 108(23):2851-6. PubMed ID: 14623806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice?
    Brodie BR
    Catheter Cardiovasc Interv; 2008 May; 71(6):816-21. PubMed ID: 18412079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.
    Saw J; Lincoff AM; DeSmet W; Betriu A; Rutsch W; Wilcox RG; Kleiman NS; Wolski K; Topol EJ;
    J Am Coll Cardiol; 2004 Sep; 44(6):1194-9. PubMed ID: 15364319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2.
    Wong CK; Gao W; Raffel OC; French JK; Stewart RA; White HD;
    Lancet; 2006 Jun; 367(9528):2061-7. PubMed ID: 16798389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
    Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
    JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial.
    Ellis SG; Armstrong P; Betriu A; Brodie B; Herrmann H; Montalescot G; Neumann FJ; Smith JJ; Topol E;
    Am Heart J; 2004 Apr; 147(4):E16. PubMed ID: 15077099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes.
    Wong CK; French JK; Aylward PE; Stewart RA; Gao W; Armstrong PW; Van De Werf FJ; Simes RJ; Raffel OC; Granger CB; Califf RM; White HD;
    J Am Coll Cardiol; 2005 Jul; 46(1):29-38. PubMed ID: 15992631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
    Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
    Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE).
    Czarnecki A; Welsh RC; Yan RT; DeYoung JP; Gallo R; Rose B; Grondin FR; Kornder JM; Wong GC; Fox KA; Gore JM; Goodman SG; Yan AT; ;
    Can J Cardiol; 2012; 28(1):40-7. PubMed ID: 22129488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.